Sloan-Kettering Cancer Center Memorial, 10% Owner at Actinium Pharmaceuticals, Inc. (ATNM), sold 3,100 shares at $1.80 ($6K) on 2016-07-12, disclosed to the SEC on 2016-07-14.
Open-market sale of $6k ATNM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.80 | 3,000 | $5K | 96.8% |
| 2 | $1.81 | 100 | $181 | 3.2% |
| Total | $1.80 avg | 3,100 | $6K | 100% |
| Filing → |
| ATNM | SELL | 2016-08-17 | $17K | — | Filing → |
| ATNM | SELL | 2016-07-12 | $40K | — | Filing → |
| ATNM | SELL | 2016-07-07 | $38K | — | Filing → |